A comparison of the levels of immune cells, circulating tumour cells as well as cell free DNA, RNA, proteins and exosomes from patient blood with that of primary or metastatic tumour tissue before and after treatment.
Participants with uveal melanoma are asked to donate blood for analysis before and after treatment.
Trial Registry Number: No ACTRN.
